Basit öğe kaydını göster

dc.contributor.authorHamilton, James P.
dc.contributor.authorDuran, Rafael
dc.contributor.authorLin, MingDe
dc.contributor.authorPawlik, Timothy M.
dc.contributor.authorHong, Kelvin
dc.contributor.authorFrangakis, Constantine
dc.contributor.authorSohn, Jae Ho
dc.contributor.authorBas, Ahmet
dc.contributor.authorChapiro, Julius
dc.contributor.authorSchernthaner, Ruediger E.
dc.date.accessioned2021-12-10T10:09:54Z
dc.date.available2021-12-10T10:09:54Z
dc.identifier.citationFrangakis C., Sohn J. H. , Bas A., Chapiro J., Schernthaner R. E. , Lin M., Hamilton J. P. , Pawlik T. M. , Hong K., Duran R., "Longitudinal Analysis of the Effect of Repeated Transarterial Chemoembolization for Liver Cancer on Portal Venous Pressure", FRONTIERS IN ONCOLOGY, cilt.11, 2021
dc.identifier.issn2234-943X
dc.identifier.othervv_1032021
dc.identifier.otherav_2cec2a62-dd28-4722-bed7-0cda3158b34a
dc.identifier.urihttp://hdl.handle.net/20.500.12627/169316
dc.identifier.urihttps://doi.org/10.3389/fonc.2021.639235
dc.description.abstractObjectivesInvestigate long-term effects of repeated transarterial chemoembolization (TACE) on portal venous pressure (PVP) using non-invasive surrogate markers of portal hypertension. MethodsRetrospective, Institutional Review Board-approved study. 99 patients [hepatocellular carcinoma (HCC) group (n=57); liver metastasis group (n=42)] who underwent 279TACEs and had longitudinal pre-/post-therapy contrast-enhanced-MRI (n=388) and complete blood work were included. Outcomes of interest were platelet count (PC), spleen volume, ascites and portosystemic collaterals. Variables included TACE type/number, tumor type, microcatheter location, Child-Pugh, baseline tumor burden (tumor number/total/largest size), vessel invasion, alpha-fetoprotein, Eastern Cooperative Oncology Group (ECOG) performance status, and Model for End-Stage Liver Disease (MELD) score. Generalized Estimating Equations assessed the associations between TACE and outcomes. Power analysis determined the sample size was sufficient. ResultsNo significant change in PC over time was observed in either groups, regardless of liver function (P>0.05). Baseline spleen volume was 226 cm(3) for metastatic group, and was larger by 204 cm(3) for HCC group (P<0.001). Spleen volume increased by 20 cm(3) (95%CI: 8-32; P=0.001) for both groups after 1(st)TACE and by 16cm(3)/TACE (P=0.099) over the full follow-up (up to 9TACEs). Spleen volume also tended to increase by 23cm(3) (95%CI: -1-48; P=0.064) with higher tumor burden. Odds of developing moderate/severe ascites for metastatic patients was decreased by 0.5 (95%CI: 0.3-0.9; P=0.014), regardless of the Child-Pugh, and increased by 1.5 (95%CI: 1.2-1.9; P<0.001) among HCC patients with unstable Child-Pugh, whereas no change was noted with stable Child-Pugh. HCC patients with unstable Child-Pugh demonstrated a significant increase in portosystemic collaterals number over time (P=0.008). PVP-related complications such as variceal bleeding post-TACE were low (0.4%). ConclusionRepeated TACEs did seem to have an impact on PVP. However, the increase in PVP had marginal effects with low portal hypertension-related complications.
dc.language.isoeng
dc.subjectOnkoloji
dc.subjectOncology
dc.subjectHealth Sciences
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titleLongitudinal Analysis of the Effect of Repeated Transarterial Chemoembolization for Liver Cancer on Portal Venous Pressure
dc.typeMakale
dc.relation.journalFRONTIERS IN ONCOLOGY
dc.contributor.departmentJohns Hopkins University , ,
dc.identifier.volume11
dc.contributor.firstauthorID2770887


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster